LONG-TERM TREATMENT WITH SUBCUTANEOUS VEDOLIZUMAB IN CROHN’S DISEASE: INTERIM RESULTS FROM THE VISIBLE OPEN-LABEL EXTENSION STUDY

Silvio Danese ¹
¹ Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute

Topic
Disease Mechanisms, IBD

Session
IBD: Clinical trials poster I

Conference
UEG Week Virtual 2021

Do you need help setting up your myUEG account?
Contact us at [email protected]

Social Sharing